Gilmelisib |
| Catalog No.GC64778 |
Gilmelisib is an antineoplastic. Gilmelisib is a PI3K inhibitor (IC50 <1 nM for PI3K p110α) extracted from WO2017101847 A1, compound 1.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1845777-61-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Gilmelisib is an antineoplastic. Gilmelisib is a PI3K inhibitor (IC50
[1]. WO2017101847 A1
[2]. International Nonproprietary Names for Pharmaceutical Substances (INN)
Review for Gilmelisib
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Gilmelisib
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *